AriBioLab Co.,Ltd. (KOSDAQ:261780)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,900.00
+240.00 (6.56%)
At close: Oct 16, 2026

AriBioLab Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
109,25475,89482,084151,036131,749293,364
Market Cap Growth
58.55%-7.54%-45.65%14.64%-55.09%-
Enterprise Value
99,80255,70553,558123,50097,133290,192
Last Close Price
3900.002825.003060.005650.004985.0011100.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
630.94478.48221.45513.51734.04586.73
PB Ratio
11.056.402.964.263.957.41
P/TBV Ratio
11.326.532.984.273.957.41

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-351.19144.49419.89541.18580.38

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.630.750.350.120.710.53
Net Debt / Equity Ratio
-0.96-1.25-1.10-0.98-1.02-1.03
Net Debt / EBITDA Ratio
0.751.074.245.875.646.97
Net Debt / FCF Ratio
1.031.333.696.206.067.51
Asset Turnover
0.010.000.010.010.000.01
Quick Ratio
1.651.494.2148.572.182.50
Current Ratio
1.921.664.6452.442.202.50
Return on Equity (ROE)
-92.28%-81.07%-32.11%-5.09%-18.40%-89.44%
Return on Assets (ROA)
-25.28%-23.16%-10.42%-7.56%-6.40%-8.35%
Return on Capital Employed (ROCE)
-113.10%-105.00%-20.50%-14.50%-18.90%-15.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-13.20%-21.14%-12.35%-1.16%-5.10%-6.28%
FCF Yield
-8.42%-14.67%-10.08%-3.69%-4.28%-1.85%
Buyback Yield / Dilution
-0.19%-0.13%-1.18%-0.30%-13.35%-30.03%